Posterior reversible encephalopathy syndrome as a consequence of high dose steroid administration after autologous PBSCT

Bone Marrow Transplantation

Volumn 45, Issue 4, 2010, Pages 779-780

  Sukumaran, S ^a   George, B ^a   Nair, H P ^a   Drobyski, W R ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; DEXAMETHASONE; LENALIDOMIDE; MELPHALAN; STEROID;

ADULT; ANEMIA; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; BLOOD PRESSURE REGULATION; BLURRED VISION; BONE DISEASE; CANCER RADIOTHERAPY; CASE REPORT; CECUM DISEASE; COLONOSCOPY; DIARRHEA; DOSE RESPONSE; DRUG MEGADOSE; DRUG WITHDRAWAL; ENDOMETRIUM CARCINOMA; ENGRAFTMENT; FEMALE; FEVER; GRAFT VERSUS HOST REACTION; HEADACHE; HUMAN; HUMAN TISSUE; HYPERTENSION; LETTER; LOW DRUG DOSE; MULTIPLE MYELOMA; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; PRIORITY JOURNAL; RASH; SINGLE DRUG DOSE; TUMOR BIOPSY;

DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKOENCEPHALOPATHIES; MIDDLE AGED; MULTIPLE MYELOMA; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; STEROIDS; SYNDROME; TRANSPLANTATION, AUTOLOGOUS;

EID: 77950629302     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2009.211     Document Type: Letter

References (11)

1. Hinchey J, Chaves C, Appignani B, Breen J, Pao L, Wang A et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med. 1996; 334: 494-500.
2. Lee VH, Wijdicks EFM, Manno EM, Rabinstein AA. Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Arch Neurol 2008; 65: 205-210.
3. Bhatt BD, Meriano FV, Buchwald D. Cyclosporine-associated central nervous system toxicity. N Engl J Med 1988; 318: 788.
4. Eidelman EH, Abu-Elmagd K, Wilson J, Fung JJ, Alessiani M, Jain A et al. Neurologic complications of FK 506. Transplant Proc 1991; 23: 3175-3178.
5. Drobyski WR, Hari P, Keever-Taylor CA, Komorowski R, Grossman W. Severe autologous graft versus host disease after hematopoietic progenitor cell transplantation for multiple myeloma. Bone Marrow Transplant 2009; 43: 169-177.
6. Hauser RA, Lacey DM, Knight MR. Hypertensive encephalopathy: magnetic resonance imaging demonstration of reversible cortical and white matter lesions. Arch Neurol 1988; 45: 1078-1083.
7. Raroque Jr HG, Orrison WW, Rosenberg GA. Neurologic involvement in toxemia of pregnancy: reversible MRI lesions. Neurology 1990; 40: 167-169.
8. Bartynski WS, Boardman JF, Zeigler ZR et al. Posterior reversible encephalopathy syndrome in infection, sepsis, and shock. Am J Neuroradiol 2006; 27: 2179-2190.
9. Lanzino G, Cloft H, Hemstreet MK, West K, Alston S, Ishitani M. Reversible posterior leukoencephalopathy following organ transplantation: Description of two cases. Clin Neurol Neurosurg 1997; 99: 222-226.
10. Allen JA, Adlakha A, Bergethon PR. Reversible posterior leukoencephalopathy syndrome after bevacizumab/FOLFIRI regimen for metastatic colon cancer. Arch Neurol 2006; 63: 1475-1478.
11. Schwartz RB. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996; 334: 1743.